{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/breast-cancer-recognition-referral/","result":{"data":{"firstChapter":{"id":"6c673d03-bace-56b7-a53f-a597bcdc5292","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field d565a823-e23b-487a-b747-950efeb97d4d --><h1>Breast cancer - recognition and referral: Summary</h1><!-- end field d565a823-e23b-487a-b747-950efeb97d4d -->","htmlStringContent":"<!-- begin item b3d82e0a-c96b-4fb9-814c-504492c6e188 --><!-- begin field d2d38d46-d52c-4bd2-a5c6-65b435b3234d --><ul><li>Approximately 50,000 new cases of breast cancer are diagnosed each year in the UK, around a quarter of these following screening mammography.</li><li>A full time GP is likely to diagnosis 1–2 cases every year.</li><li>Breast cancer is less common in males.</li><li>The 5-year survival is 85%, although this figure includes cases detected by screening as well as those identified after symptoms have occurred.</li><li>Breast lump is the most common presenting symptom.</li><li>A malignant breast lump is usually painless, but pain can occur.</li><li>Nipple symptoms, including change in shape or nipple bleeding, are recognized symptoms as are skin changes, such as tethering or peau d’orange.</li><li>A diagnosis of breast cancer is generally made by mammography and core biopsy. This is performed in secondary care.</li><li>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for breast cancer if they are:<ul><li>Aged 30 years and over and have an unexplained breast lump with or without pain, or</li><li>Aged 50 years and over with any of the following symptoms in one nipple only:<ul><li>Discharge.</li><li>Retraction.</li><li>Other changes of concern.</li></ul></li></ul></li><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for breast cancer in people:<ul><li>With skin changes that suggest breast cancer, or</li><li>Aged 30 years and over with an unexplained lump in the axilla.</li></ul></li><li>Consider non-urgent referral in people aged under 30 years with an unexplained breast lump with or without pain.</li></ul><!-- end field d2d38d46-d52c-4bd2-a5c6-65b435b3234d --><!-- end item b3d82e0a-c96b-4fb9-814c-504492c6e188 -->","topic":{"id":"23601748-b432-5cfc-bb6e-eda9fbdeee22","topicId":"f25be291-090b-4b09-8066-12f2751f720f","topicName":"Breast cancer - recognition and referral","slug":"breast-cancer-recognition-referral","aliases":[],"chapters":[{"id":"6c673d03-bace-56b7-a53f-a597bcdc5292","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"fc5e3db0-7e24-5799-9fbb-cfdb2f0add15","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"f3e27a8d-5986-5a93-a492-92cadc86ff6e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"9790b1c9-49ce-5bb2-8b79-5c11b23f1cd6","slug":"changes","fullItemName":"Changes"},{"id":"94270ff8-24fe-5ff7-aae5-3900089ae608","slug":"update","fullItemName":"Update"}]},{"id":"fd2fee21-53df-51dd-868c-643a9f0e65be","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7d7641d6-0605-54a3-ab59-a1bd0dc28a33","slug":"goals","fullItemName":"Goals"},{"id":"3d72f80d-a8bc-5bf4-a847-9772d5943ce8","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ffdec7ba-48b9-5c4a-846d-3924006e35c8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"97660e9f-40af-52d4-b32a-634edc6bd90f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"008aa5de-eb42-5d5c-a871-b61e5daba394","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f6cc3750-6fa3-5d3e-bb7c-08051147b469","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8ad9c095-3478-5d9a-ba4f-498fb1068e3a","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"39f3817f-dbfc-50ff-bab8-a772fc5b4857","slug":"presentation","fullItemName":"Presentation"},{"id":"aee728aa-816a-53f1-a56e-fcf21c58934b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9e8f703d-2404-5ba6-961f-1b558e49f4f1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4174df43-b098-564e-9f19-7ef18fa4fdb8","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"24d948fd-9c7d-57df-b315-b57bbebe801d","slug":"symptoms-suggestive-of-breast-cancer","fullItemName":"Symptoms suggestive of breast cancer"}]},{"id":"173a80e5-0e43-5ec5-921d-2e3ca88853e8","slug":"management","fullItemName":"Management","subChapters":[{"id":"edfd8b4a-6489-57ad-a1cd-8f18f50ec82f","slug":"referral-for-breast-cancer","fullItemName":"Scenario: Referral for breast cancer"}]},{"id":"bc73dfc4-3996-50ab-9fb8-0b8c8f9e8e46","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"e0bb6a20-1a55-5063-be1d-7095847278ac","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"9644a4bf-c859-5d55-915b-c70e2ffbd2c3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8333c01c-ab5b-5a34-a56c-e8ddd4028c07","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c611b59d-6fc6-5d02-8d09-f1231d448133","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3d8c7032-7729-568d-9d93-350c90a6a199","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3823a13f-679e-528e-b3bd-c4f0d44702b8","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"51fab6ab-aa31-52ef-ac3e-7a61a5e1aaec","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"23601748-b432-5cfc-bb6e-eda9fbdeee22","topicId":"f25be291-090b-4b09-8066-12f2751f720f","topicName":"Breast cancer - recognition and referral","slug":"breast-cancer-recognition-referral","aliases":[],"topicSummary":"Approximately 50,000 new cases of breast cancer are diagnosed each year in the UK, around a quarter of which through screening mammography.","lastRevised":"Last revised in August 2020","nextPlannedReviewBy":"2025-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2025-07","nextPlannedReviewByDisplay":"July 2025","specialities":[{"id":"46239e57-7990-560a-810f-b31000558649","name":"Cancer","slug":"cancer"}],"chapters":[{"id":"6c673d03-bace-56b7-a53f-a597bcdc5292","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"fc5e3db0-7e24-5799-9fbb-cfdb2f0add15","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"f3e27a8d-5986-5a93-a492-92cadc86ff6e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"9790b1c9-49ce-5bb2-8b79-5c11b23f1cd6","slug":"changes","fullItemName":"Changes"},{"id":"94270ff8-24fe-5ff7-aae5-3900089ae608","slug":"update","fullItemName":"Update"}]},{"id":"fd2fee21-53df-51dd-868c-643a9f0e65be","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7d7641d6-0605-54a3-ab59-a1bd0dc28a33","slug":"goals","fullItemName":"Goals"},{"id":"3d72f80d-a8bc-5bf4-a847-9772d5943ce8","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ffdec7ba-48b9-5c4a-846d-3924006e35c8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"97660e9f-40af-52d4-b32a-634edc6bd90f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"008aa5de-eb42-5d5c-a871-b61e5daba394","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f6cc3750-6fa3-5d3e-bb7c-08051147b469","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8ad9c095-3478-5d9a-ba4f-498fb1068e3a","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"39f3817f-dbfc-50ff-bab8-a772fc5b4857","slug":"presentation","fullItemName":"Presentation"},{"id":"aee728aa-816a-53f1-a56e-fcf21c58934b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9e8f703d-2404-5ba6-961f-1b558e49f4f1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4174df43-b098-564e-9f19-7ef18fa4fdb8","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"24d948fd-9c7d-57df-b315-b57bbebe801d","slug":"symptoms-suggestive-of-breast-cancer","fullItemName":"Symptoms suggestive of breast cancer"}]},{"id":"173a80e5-0e43-5ec5-921d-2e3ca88853e8","slug":"management","fullItemName":"Management","subChapters":[{"id":"edfd8b4a-6489-57ad-a1cd-8f18f50ec82f","slug":"referral-for-breast-cancer","fullItemName":"Scenario: Referral for breast cancer"}]},{"id":"bc73dfc4-3996-50ab-9fb8-0b8c8f9e8e46","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"e0bb6a20-1a55-5063-be1d-7095847278ac","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"9644a4bf-c859-5d55-915b-c70e2ffbd2c3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8333c01c-ab5b-5a34-a56c-e8ddd4028c07","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c611b59d-6fc6-5d02-8d09-f1231d448133","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3d8c7032-7729-568d-9d93-350c90a6a199","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3823a13f-679e-528e-b3bd-c4f0d44702b8","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"51fab6ab-aa31-52ef-ac3e-7a61a5e1aaec","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"23601748-b432-5cfc-bb6e-eda9fbdeee22"}},"staticQueryHashes":["3666801979"]}